10 completed, 3 withdrawn, 2 unknown, 1 terminated. 16 Phase 2, 5 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 16 | Completed 10, Withdrawn 3, Unknown 2, Terminated 1 |
| Phase 1 | 5 | Completed 3, Terminated 1, Withdrawn 1 |
| Phase 3 | 1 | Completed 1 |
Follow Hypertonic Saline: new trials by email Literature Review of Hypertonic Saline trials Research Report on Hypertonic Saline
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Aim of This Study is to Compare the Efficacy of Perioperative Hypertonic Saline 3% Versus Normal Saline (0.9%) in Decreasing Recurrence Risk in Non-muscle Invasive Bladder Cancer Hypertonic Saline - TCC | Phase 2 | Unknown | Kaplan Medical Center | 150 | 2021-01-20 | 2021-02-18 |
| Safety & Tolerability of Hypertonic Saline Administration Via Intraosseous Access Intraosseous, Hypertonic saline - Stroke, Intracranial Hypotension | Phase 2 | Completed | Ohio State University | 6 | 2017-04-21 | 2019-07-09 |
| Clearing Lungs With ENaC Inhibition in Primary Ciliary Dyskinesia VX-371, Hypertonic Saline, Placebo (0.17% saline) - Primary Ciliary Dyskinesia | Phase 2 | Completed | Parion Sciences | 123 | 2016-08-01 | 2021-12-16 |
| A Study to Evaluate the Safety and Efficacy of VX-371 in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation VX-371 + HS, Hypertonic saline, Placebo - Cystic Fibrosis | Phase 2 | Completed | Parion Sciences | 147 | 2016-02-01 | 2021-07-29 |
| IVF in Pediatric Concussion Hypertonic Saline - Pediatric Mild Traumatic Brain Injury | Phase 1 / Phase 2 | Terminated | Washington University School of Medicine | 2 | 2015-10-01 | 2016-04-28 |
| Study of Stroke Related Edema Treatments Conivaptan, Hypertonic saline, Mannitol - Acute Cerebrovascular Accident, Cerebral Edema | Phase 2 | Withdrawn | University of Florida | 2015-09-01 | 2016-12-14 | |
| Clearing Lungs With Epithelial Sodium Channel (ENaC) Inhibition in Cystic Fibrosis (CF) P-1037, Hypertonic Saline, Saline - Cystic Fibrosis | Phase 2 | Completed | Parion Sciences | 142 | 2015-04-01 | 2021-07-26 |
| Treating Wheezing in Children With Hypertonic Saline (TWICS) hypertonic saline, saline - Wheeze | Phase 2 | Withdrawn | Dr. Michael Flavin | 2013-10-01 | 2015-11-13 | |
| Aerosolized Hypertonic Xylitol Versus Hypertonic Saline in Cystic Fibrosis (CF) Subjects Xylitol, Hypertonic saline - Cystic Fibrosis | Phase 1 / Phase 2 | Completed | Joseph Zabner | 63 | 2013-01-22 | 2021-06-25 |
| Inhaled Xylitol Versus Saline in Stable Subjects With Cystic Fibrosis Xylitol, Hypertonic saline - Cystic Fibrosis | Phase 1 / Phase 2 | Completed | Joseph Zabner | 30 | 2011-05-01 | 2018-10-24 |
| Hypertonic Saline as Therapy for Pediatric Concussion Hypertonic Saline, Normal Saline - Pain | Phase 1 / Phase 2 | Completed | University of California, San Diego | 44 | 2010-03-01 | 2019-04-16 |
| Hypertonic Saline (6%) Versus Isotonic Saline (0.9%) in Bronchiectasis Hypertonic saline, Isotonic saline - Bronchiectasis | Phase 2 | Unknown | Belfast Health and Social Care Trust | 20 | 2010-01-01 | 2010-04-28 |
| Nebulized Hypertonic Saline for Bronchiolitis Nebulized 3% saline, Nebulized 0.9% saline - Bronchiolitis | Phase 2 / Phase 3 | Completed | Children's Hospital Los Angeles | 447 | 2008-02-01 | 2024-11-05 |
| Hypertonic Saline and Mucociliary Clearance in Children 0.12% saline, 7% saline - Cystic Fibrosis | Phase 2 | Completed | Johns Hopkins University | 17 | 2007-07-01 | 2015-09-22 |
| Utility of Induced Sputum Using Hypertonic Saline to Evaluate Infection and Inflammation in Cystic Fibrosis Hypertonic Saline - Cystic Fibrosis | Phase 2 | Completed | The Hospital for Sick Children | 95 | 2006-12-01 | 2013-09-02 |
| Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies Edetate Calcium Disodium, Ethanol, Trimethoprim-sulfamethoxazole - Chronic Myeloproliferative Disorders, Infection | Phase 1 / Phase 2 | Withdrawn | M.D. Anderson Cancer Center | 2013-02-15 |
Cystic Fibrosis (6) · Brain Edema (2) · Bronchiolitis (2) · Stroke (2) · Asthma (1) · Blast Crisis (1) · Bronchiectasis (1) · Burkitt Lymphoma (1) · Ciliary Motility Disorders (1) · Congenital Abnormalities (1) · Hodgkin Disease (1) · Immunoblastic Lymphadenopathy (1) · Immunoglobulin Light-chain Amyloidosis (1) · Infections (1) · Intracranial Hypotension (1)
Parion Sciences (3) · Joseph Zabner (2) · Belfast Health and Social Care Trust (1) · Children's Hospital Los Angeles (1) · Dr. Michael Flavin (1) · Johns Hopkins University (1) · Kaplan Medical Center (1) · M.D. Anderson Cancer Center (1) · Ohio State University (1) · The Hospital for Sick Children (1) · University of California, San Diego (1) · University of Florida (1) · Washington University School of Medicine (1)
United States (9) · United Kingdom (3) · Canada (2) · Denmark (1) · France (1) · Germany (1) · Ireland (1) · Israel (1) · Italy (1) · Netherlands (1) · Poland (1)
Karl Donn (2) · Alison Church, MD (1) · Angela K Lumba, MD (1) · Beth L Laube, PhD (1) · Felix Ratjen, MD (1) · Jan L Launspach, R.N., CCRC (1) · Jorge Cortes, MD (1) · Joseph Zabner, M.D. (1) · Joseph Zabner, MD (1) · Lakshmi Durairaj, M.D. (1) · Lakshmi Durairaj, MD (1) · Mary Hilfiker, MD (1) · Michael F Waters, MD (1) · Michael Flavin (1) · Patrick Chaftari, MD (1)
PMID 20630539, PMID 21896198, PMID 24862623, PMID 31327670, PMID 32671834, PMID 34674574, PMID 37660715
2015 (2)